Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Titel:
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Auteur:
Wheeler, Cosette M Skinner, S Rachel Del Rosario-Raymundo, M Rowena Garland, Suzanne M Chatterjee, Archana Lazcano-Ponce, Eduardo Salmerón, Jorge McNeil, Shelly Stapleton, Jack T Bouchard, Céline Martens, Mark G Money, Deborah M Quek, Swee Chong Romanowski, Barbara Vallejos, Carlos S ter Harmsel, Bram Prilepskaya, Vera Fong, Kah Leng Kitchener, Henry Minkina, Galina Lim, Yong Kuei Timothy Stoney, Tanya Chakhtoura, Nahida Cruickshank, Margaret E Savicheva, Alevtina da Silva, Daniel Pereira Ferguson, Murdo Molijn, Anco C Quint, Wim G V Hardt, Karin Descamps, Dominique Suryakiran, Pemmaraju V Karkada, Naveen Geeraerts, Brecht Dubin, Gary Struyf, Frank